Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

438 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Development and validation of a screening score for prediabetes and undiagnosed diabetes.].
Rojas-Martínez R, Escamilla-Núñez C, Gómez-Velasco DV, Zárate-Rojas E, Aguilar-Salinas CA; Grupo colaborador de la cohorte para estimar la incidencia del síndrome metabólico; Grupo colaborador de la cohorte para estimar la incidencia del síndrome metabólico*. Rojas-Martínez R, et al. Salud Publica Mex. 2018 Sep-Oct;60(5):500-509. doi: 10.21149/9057. Salud Publica Mex. 2018. PMID: 30550111 Spanish.
Diabetes knowledge and its determinants in a Mexican population.
Bautista-Martinez S, Aguilar-Salinas CA, Lerman I, Velasco ML, Castellanos R, Zenteno E, Guillen LE, Murcio R, Wong B, Gómez Pérez FJ, Rull-Rodrigo JA. Bautista-Martinez S, et al. Diabetes Educ. 1999 May-Jun;25(3):374-81. doi: 10.1177/014572179902500308. Diabetes Educ. 1999. PMID: 10531857
Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study.
Aguilar-Salinas CA, Gómez-Pérez FJ, Posadas-Romero C, Vázquez-Chávez C, Meaney E, Gulías-Herrero A, Guillén LE, Alvarado Vega A, Mendoza Pérez E, Eduardo Romero-Nava L, Angélica Gómez-Díaz R, Salinas-Orozco S, Moguel R, Novoa G. Aguilar-Salinas CA, et al. Atherosclerosis. 2000 Oct;152(2):489-96. doi: 10.1016/s0021-9150(99)00502-x. Atherosclerosis. 2000. PMID: 10998478 Clinical Trial.
Further insight on the hypoglycemic and nonhypoglycemic effects of troglitazone 400 or 600 mg/d: effects on the very-low-density and high-density lipoprotein particle distribution.
Gómez-Pérez FJ, Aguilar-Salinas CA, Vázquez-Chávez C, Fanghänel-Salmón G, Gallegos-Martínez J, Gómez-Diaz RA, Salinas-Orozco S, Chavira-López IJ, Sánchez-Reyes L, Torres-Acosta EM, Tamez R, López A, Guillén LE, Cesarman G. Gómez-Pérez FJ, et al. Metabolism. 2002 Jan;51(1):44-51. doi: 10.1053/meta.2002.29024. Metabolism. 2002. PMID: 11782871 Clinical Trial.
438 results